NL-OMON28184已完成不适用
Docetaxel and Carboplatin once every 3 weeks versus weekly Docetaxel in advanced non-small cell lung cancer: a Multicenter phase III study from the Dutch Chest Physician Association.
MCGDepartment Pulmonary Diseases0 个研究点目标入组 440 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 440
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Histological or cytological diagnosis of unresectable (stage III-b, pleuritis carcinomatosa) or disseminated (stage IV) NSCLS;
- •2. Age ≥ 18 years;
排除标准
- •1. Other serious diseases, such as heart failure, angina pectoris, myocardial infarction within the last 6 months, uncontrolled hypertension, active infection or significant psychiatric illness;
- •2. Symptomatic brain metastases;
研究者
相似试验
已完成
2 期
Docetaxel,Cisplatin versus Carboplatin,weekly Paclitaxel for patients with advanced non-small cell lung cancer : a prospective randomized phase II study of the Niigata Lung Cancer Treatment Groupon-small cell lung cancerJPRN-UMIN000001132iigata Lung Cancer Treatment Group80
进行中（未招募）
不适用
Weekly therapy with Carboplatin and Docetaxel in patients with head-neck cancer with important comorbidity (ancer patients with chronic cardiac or circulatory disorders, people who have had cardiovascular accidents in the past, people with renal failure, etc.).Patients with head and neck cancer having high comorbidityMedDRA version: 14.1Level: SOCClassification code 10029104Term: Neoplasms benign, malignant and unspecified (incl cysts and polyps)System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2011-003509-65-ITISTITUTO ONCOLOGICO VENETO
招募中
不适用
Docetaxel versus Docetaxel and Lapatinib in recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN). An open label multicenter randomized phase II study.A study of the Dutch Head and Neck Cancer Group (DHNCG)(NWHHT 08-02).patients with recurrent SCCHN not amendable for local therapy or patients with metastatic SCCHNKeywords: SCCHN, recurrent and/or metastatic disease, docetaxel, lapatinibNL-OMON22962The Netherlands Cancer Institute Antoni van Leeuwenhoek hospitalDutch Head and Neck Cancer Group (DHNCG)74
终止
1 期
Docetaxel and Carboplatin in Treating Patients With Recurrent Stage IVB Squamous Cell Carcinoma (Cancer) of the CervixCervical CancerNCT00084890Wake Forest University Health Sciences15
已完成
2 期
Docetaxel in combination with either cisplatin (DC) or gemcitabine (DG) in unresectable non-small sell lung carcinoma (NSCLC)on-small sell lung carcinoma (NSCLC)JPRN-C000000310The Tokyo cooperative oncology group150